HealthDay News — On Tuesday, the US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors may exit the stock.

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5% ...

US pharmaceutical company Moderna could be suspended or expelled from a UK trade body due to breaches of industry regulations ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

A US pharmaceutical giant could face suspension in the UK for engaging in “unacceptable practices” Read Full Article at ...

Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

New research from Murdoch University's Australian National Phenome Center confirms that multiple doses of COVID-19 vaccines ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.